Search

everythinglearnresearchcommunity

for

Search:↓

Two new enzymes, PAD-R11 and PAD-R4, were cloned and showed activity, with PAD-R11 resembling epidermal enzymes.

A boronic acid copolymer quickly forms cell clusters, useful for tissue and tumor modeling.

JAK inhibitors offer new hope for treating severe alopecia areata.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Janus kinase inhibitors may help treat lichen planopilaris.

DPP may help hair regrowth by improving blood vessel function under stress.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

DA-9401 helps protect rat testis from finasteride damage.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Newly made nicotinamide compounds could potentially treat cancer.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

CS12192 effectively treats alopecia areata with better safety than current options.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Two new compounds were found to effectively reduce hair growth in mice.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.